These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29466861)

  • 1. Flexibility-Not just for yoga anymore!
    Seley-Radtke K
    Antivir Chem Chemother; 2018; 26():2040206618756788. PubMed ID: 29466861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flexibility as a Strategy in Nucleoside Antiviral Drug Design.
    Peters HL; Ku TC; Seley-Radtke KL
    Curr Med Chem; 2015; 22(34):3910-21. PubMed ID: 26282942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next-Generation Reduction Sensitive Lipid Conjugates of Tenofovir: Antiviral Activity and Mechanism of Release.
    Giesler KE; Liotta DC
    J Med Chem; 2016 Nov; 59(22):10244-10252. PubMed ID: 27933889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosides.
    Du J; Surzhykov S; Lin JS; Newton MG; Cheng YC; Schinazi RF; Chu CK
    J Med Chem; 1997 Sep; 40(19):2991-3. PubMed ID: 9301659
    [No Abstract]   [Full Text] [Related]  

  • 5. L-Nucleosides as chemotherapeutic agents.
    Gumina G; Song GY; Chu CK
    FEMS Microbiol Lett; 2001 Aug; 202(1):9-15. PubMed ID: 11506901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New classes of fluorinated L-nucleosides; synthesis and antiviral activity.
    Lee K; Choi Y; Hong JH; Schinazi RF; Chu CK
    Nucleosides Nucleotides; 1999; 18(4-5):537-40. PubMed ID: 10432644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction Sensitive Lipid Conjugates of Tenofovir: Synthesis, Stability, and Antiviral Activity.
    Giesler KE; Marengo J; Liotta DC
    J Med Chem; 2016 Aug; 59(15):7097-110. PubMed ID: 27405794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-nucleoside enantiomers as antivirals drugs: a mini-review.
    Mathé C; Gosselin G
    Antiviral Res; 2006 Sep; 71(2-3):276-81. PubMed ID: 16797735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antiviral evaluation of 2-amino-6-carbamoylpurine dioxolane nucleoside derivatives and their phosphoramidates prodrugs.
    Cho JH; Bondana L; Detorio MA; Montero C; Bassit LC; Amblard F; Coats SJ; Schinazi RF
    Bioorg Med Chem; 2014 Dec; 22(23):6665-6671. PubMed ID: 25458500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Delaney WE; Locarnini S; Shaw T
    Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flex-nucleoside analogues - Novel therapeutics against filoviruses.
    Yates MK; Raje MR; Chatterjee P; Spiropoulou CF; Bavari S; Flint M; Soloveva V; Seley-Radtke KL
    Bioorg Med Chem Lett; 2017 Jun; 27(12):2800-2802. PubMed ID: 28465098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiviral nucleoside prodrugs await application.
    Anastasi C; Quéléver G; Burlet S; Garino C; Souard F; Kraus JL
    Curr Med Chem; 2003 Sep; 10(18):1825-43. PubMed ID: 12871107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleoside/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance.
    Menéndez-Arias L; Álvarez M; Pacheco B
    Curr Opin Virol; 2014 Oct; 8():1-9. PubMed ID: 24814823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro antiviral activities of [(dihydrofuran-2-yl)oxy]methyl-phosphonate nucleosides with 2-substituted adenine as base.
    Liu F; Liu Y; Xu RG; Dai G; Zhao LX; Wang Y; Liu HM; Liu FW; Pannecouque C; Herdewijn P
    Chem Biodivers; 2015 May; 12(5):813-22. PubMed ID: 26010668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acyclic nucleoside phosphonates: a key class of antiviral drugs.
    De Clercq E; Holý A
    Nat Rev Drug Discov; 2005 Nov; 4(11):928-40. PubMed ID: 16264436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
    Liu Y; Peng Y; Lu J; Wang J; Ma H; Song C; Liu B; Qiao Y; Yu W; Wu J; Chang J
    Eur J Med Chem; 2018 Jan; 143():137-149. PubMed ID: 29174810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The search for nucleoside/nucleotide analog inhibitors of dengue virus.
    Chen YL; Yokokawa F; Shi PY
    Antiviral Res; 2015 Oct; 122():12-9. PubMed ID: 26241002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct notch signaling expression patterns between nucleoside and nucleotide analogues treatment for hepatitis B virus infection.
    Wang Z; Kawaguchi K; Honda M; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
    Biochem Biophys Res Commun; 2018 Jun; 501(3):682-687. PubMed ID: 29752943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiviral activity of C-fluoro-branched cyclopropyl nucleosides.
    Kim A; Hong JH
    Eur J Med Chem; 2007 Apr; 42(4):487-93. PubMed ID: 17188402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel class of phosphonate nucleosides. 9-[(1-phosphonomethoxycyclopropyl)methyl]guanine as a potent and selective anti-HBV agent.
    Choi JR; Cho DG; Roh KY; Hwang JT; Ahn S; Jang HS; Cho WY; Kim KW; Cho YG; Kim J; Kim YZ
    J Med Chem; 2004 May; 47(11):2864-9. PubMed ID: 15139764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.